Orbimed Advisors - PASSAGE BIO INC ownership

PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PASSAGE BIO INC
ValueSharesWeighting
Q3 2023$6,661,971
-30.1%
10,124,5760.0%0.14%
-17.9%
Q2 2023$9,530,263
+11.4%
10,124,576
+13.4%
0.17%
+3.0%
Q1 2023$8,554,175
-30.6%
8,931,9990.0%0.17%
-28.8%
Q4 2022$12,326,159
+10.4%
8,931,9990.0%0.24%
+14.0%
Q3 2022$11,165,000
-47.0%
8,931,9990.0%0.21%
-45.8%
Q2 2022$21,080,000
-7.3%
8,931,999
+21.8%
0.38%
+3.5%
Q1 2022$22,729,000
-48.6%
7,331,999
+5.3%
0.37%
-35.0%
Q4 2021$44,214,000
-36.2%
6,962,8990.0%0.57%
-25.5%
Q3 2021$69,350,000
-24.8%
6,962,8990.0%0.76%
-18.2%
Q2 2021$92,189,000
-24.3%
6,962,8990.0%0.93%
-18.1%
Q1 2021$121,711,000
-31.6%
6,962,8990.0%1.14%
-27.0%
Q4 2020$178,041,000
+95.0%
6,962,8990.0%1.56%
+35.8%
Q3 2020$91,284,000
-52.0%
6,962,8990.0%1.15%
-57.2%
Q2 2020$190,296,000
+73.5%
6,962,8990.0%2.68%
+45.4%
Q1 2020$109,666,0006,962,8991.84%
Other shareholders
PASSAGE BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,497,922$63,872,00014.76%
FRAZIER MANAGEMENT LLC 5,009,219$128,086,0009.86%
HIGHLINE CAPITAL MANAGEMENT, L.P. 602,248$15,399,0007.53%
Vivo Capital, LLC 1,487,038$38,024,0001.70%
Boxer Capital, LLC 1,928,315$49,307,0001.58%
Orbimed Advisors 6,962,899$178,041,0001.56%
Logos Global Management LP 344,438$8,807,0000.76%
EMERALD ADVISERS, LLC 340,698$8,712,0000.29%
Ikarian Capital, LLC 136,697$3,495,0000.15%
Weiss Multi-Strategy Advisers LLC 300,554$7,685,0000.15%
View complete list of PASSAGE BIO INC shareholders